Cleared Traditional

K062274 - SPACER-K TEMPORARY KNEE SPACER WITH GEN...

K062274 is an FDA 510(k) clearance for SPACER-K TEMPORARY KNEE SPACER WITH GEN..., manufactured by Tecres S.P.A.. The device is a Class 2 Orthopedic device with product code JWH cleared through the Traditional 510(k) pathway after a 654-day FDA review.

K062274 · Tecres S.P.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2008
Decision
654d
Days
Class 2
Risk

K062274 is an FDA 510(k) clearance for the SPACER-K TEMPORARY KNEE SPACER WITH GENTAMICIN, MODELS SPK0021, SPK0121, SPK0.... Classified as Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer (product code JWH), Class II - Special Controls.

Submitted by Tecres S.P.A. (Gainesville, US). The FDA issued a Cleared decision on May 22, 2008 after a review of 654 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Tecres S.P.A. devices

FDA 510(k) Submission Details - K062274

510(k) Number K062274 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 2006
Decision Date May 22, 2008
Days to Decision 654 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
532d slower than avg
Panel avg: 122d · This submission: 654d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JWH Device Classification - Class 2, Special Controls

Product Code JWH Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - JWH Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer

All 801
Devices cleared under the same product code (JWH) and FDA review panel - the closest regulatory comparables to K062274.
OPTETRAK 9MM CRUCIATE RETAINING TIBIAL INSERT, SLOPE ++
K082022 · Exactech, Inc. · Sep 2008
E-POLY TIBIAL BEARINGS
K080528 · Biomet Orthopedics, Inc. · Jun 2008
PROVEN STEM EXTENDER
K081458 · Stelkast Company · Jun 2008
CONFORMIS TOTAL KNEE REPIAR SYSTEM (ITOTAL) TIBIAL COMPONENT: 6.0 MM THICKNESS
K080936 · Conformis, Inc. · May 2008
VANGUARD KNEE SYSTEM TITANIUM FEMORAL COMPONENTS
K080204 · Biomet, Inc. · Mar 2008
GENDER SOLUTIONS NATURAL-KNEE FLEX SYSTEM
K073286 · Zimmer, Inc. · Mar 2008